RACHAEL KAZARIAN: Open Payments
NPI 1538753595 · PROVIDENCE, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,206 in 56 payments from 8 companies in 2025. Trend: 2023 $287 · 2024 $567 · 2025 $1,206
Food & beverage: $1,206
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $598 |
| Janssen Biotech, Inc. | 8 | $180 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $165 |
| Ardelyx, Inc. | 3 | $77 |
| Celltrion USA Inc. | 3 | $74 |
| QOL Medical, LLC | 1 | $46 |
| Gilead Sciences, Inc. | 2 | $43 |
| Lilly USA, LLC | 1 | $22 |
Products named: RINVOQ, TREMFYA, ENTYVIO, SKYRIZI, CREON, IBSRELA, VEGZELMA, Sucraid.
Industry payments across RI — which companies pay providers there.
